Systematic lncRNA mapping to genome-wide co-essential modules uncovers cancer dependency on uncharacterized lncRNAs

Ramkrishna Mitra1, Clare M Adams1, Christine M Eischen1

  • 1Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, United States.

Elife
|June 13, 2022
PubMed

Insights

Researchers identified essential long noncoding RNAs (lncRNAs) regulating cancer cell proliferation using CRISPR screens and multi-omics data. Two novel lncRNAs, PSLR-1 and PSLR-2, were found to suppress tumor growth by arresting the cell cycle.

Area of Science:

  • Genomics
  • Cancer Biology
  • RNA Biology

Background:

  • Genome-scale CRISPR screens identify essential genes in cancer cell lines.
  • Long noncoding RNAs (lncRNAs) are crucial regulators, but their essentiality is understudied due to limited loss-of-function screening methods.
  • Uncharacterized lncRNAs play significant roles in cellular processes, yet many remain undiscovered.

Purpose of the Study:

  • To develop a method for identifying essential lncRNAs using integrated genomic and transcriptomic data.
  • To discover novel lncRNAs that regulate cancer cell proliferation and growth.
  • To prioritize lncRNAs with potential as pan-cancer therapeutic targets.

Main Methods:

  • Integrated analysis of copy number, epigenetic, and transcriptomic data from over 800 cancer cell lines.
  • Utilized CRISPR-derived co-essential pathway information to predict lncRNA dependencies.
  • Prioritized lncRNAs based on dependency across cancer types and response to growth inhibitors.

Main Results:

  • Successfully recapitulated known essential lncRNAs and predicted 289 poorly characterized lncRNAs involved in proliferation.
  • Identified 30 high-confidence lncRNAs regulating proliferation across multiple cancer types.
  • Characterized two novel proliferation-suppressive lncRNAs (PSLR-1, PSLR-2) regulated by p53 and linked to patient survival.

Conclusions:

  • The study provides a powerful resource for lncRNA discovery in cancer, overcoming current screening limitations.
  • PSLR-1 and PSLR-2 modulate the FOXM1 network to induce G2 cell cycle arrest, inhibiting cancer proliferation.
  • These findings highlight the potential of lncRNAs as therapeutic targets in oncology.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K